Journal of Ovarian Research

(The TQCC of Journal of Ovarian Research is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review124
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective75
The role of oxidative stress in ovarian aging: a review62
YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells53
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment52
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age50
Withaferin A: a potential therapeutic agent against COVID-19 infection46
circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis39
Therapeutic role of curcumin and its novel formulations in gynecological cancers39
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer37
An overview of FSH-FSHR biology and explaining the existing conundrums37
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis36
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized35
Long non-coding RNAs in ovarian granulosa cells35
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses34
Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS33
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells33
Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis33
Anti-tumor activities of probiotics in cervical cancer33
MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer33
Whole-exome sequencing in patients with premature ovarian insufficiency: early detection and early intervention33
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells32
Adipocytes: active facilitators in epithelial ovarian cancer progression?31
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis31
Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway31
Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review30
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer30
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A28
Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models27
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging27
Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis26
Targeting purine metabolism in ovarian cancer26
LINC01094/miR-577 axis regulates the progression of ovarian cancer26
Association between morphologic grading and implantation rate of Euploid blastocyst25
Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients24
Comparison of methods for quantifying primordial follicles in the mouse ovary24
Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD124
The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal‐weight population24
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis24
Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells22
Prediction of the treatment response in ovarian cancer: a ctDNA approach22
Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study22
Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL121
Transcriptomics of cumulus cells – a window into oocyte maturation in humans21
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression21
Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice20
Mechanisms of ovarian aging in women: a review20
RETRACTED ARTICLE: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis20
Telomere length in granulosa cells and leukocytes: a potential marker of female fertility? A systematic review of the literature20
Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer19
The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients19
Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses18
Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments18
miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcino18
Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors18
LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p18
Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis18
Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome17
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer17
Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR17
Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer17
CACNA1C is a prognostic predictor for patients with ovarian cancer17
Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?16
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer16
UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway16
Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis16
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?16
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer16
RETRACTED ARTICLE: Long non-coding RNA PTPRG-AS1 promotes cell tumorigenicity in epithelial ovarian cancer by decoying microRNA-545-3p and consequently enhancing HDAC4 expression16
LncRNA HOTAIRM1, miR-433-5p and PIK3CD function as a ceRNA network to exacerbate the development of PCOS16
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma16
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer15
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer15
Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer15
The role of MMP-14 in ovarian cancer: a systematic review15
Role of different non-coding RNAs as ovarian cancer biomarkers15
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer15
p38β - MAPK11 and its role in female cancers15
Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis15
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications15
LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis15
Age-related decline in the expression of GDF9 and BMP15 genes in follicle fluid and granulosa cells derived from poor ovarian responders15
Long non-coding RNA THOR promotes ovarian Cancer cells progression via IL-6/STAT3 pathway14
Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism14
Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients14
Mutation analysis of the TUBB8 gene in primary infertile women with oocyte maturation arrest14
Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors14
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review14
Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?14
Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression14
The boosting effects of melatonin on the expression of related genes to oocyte maturation and antioxidant pathways: a polycystic ovary syndrome- mouse model13
Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway13
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer13
Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature13
Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-313
BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea13
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study13
TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells13
Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K13
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer13
Aged mice ovaries harbor stem cells and germ cell nests but fail to form follicles13
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study12
Comparison of dietary micronutrient intake in PCOS patients with and without metabolic syndrome12
Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer12
Ovarian microcystic stromal tumor with omental metastasis: the first case report and literature review12
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer12
LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation12
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing12
Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients12
Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA12
Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer12
Association between atypical endometriosis and ovarian malignancies in the real world12
Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer12
RETRACTED ARTICLE: LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration12
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report11
Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis11
A risk model of gene signatures for predicting platinum response and survival in ovarian cancer11
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer11
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer11
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro11
miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF911
Construction autophagy-related prognostic risk signature to facilitate survival prediction, individual treatment and biomarker excavation of epithelial ovarian cancer patients11
Predictive factors of endometriosis progression into ovarian cancer11
Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study11
Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics11
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status11
miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B11
MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD411
MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF411
Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis11
Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network11
CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer10
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer10
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer10
Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis10
Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI10
Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience10
Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway10
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer10
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling10
Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma10
Baicalin improves the functions of granulosa cells and the ovary in aged mice through the mTOR signaling pathway10
LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer10
Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway in vitro10
A poor prognostic metastatic nongestational choriocarcinoma of the ovary: a case report and the literature review10
Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture10
Trophectoderm biopsy of blastocysts for a preimplantation genetic test does not affect serum β-hCG levels in early pregnancy: a study using propensity score matching10
Clinical analysis and artificial intelligence survival prediction of serous ovarian cancer based on preoperative circulating leukocytes10
Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer10
The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p10
Effect of blastocyst morphology and developmental speed on transfer strategy for grade “C” blastocyst in vitrified‐warmed cycles10
Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome9
Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer9
Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq9
GIMAP7 induces oxidative stress and apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inhibiting sonic hedgehog signalling pathway9
Successful live birth in a Chinese woman with P450 oxidoreductase deficiency through frozen-thawed embryo transfer: a case report with review of the literature9
Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles9
A flexible short protocol in women with poor ovarian response over 40 years old9
FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization9
Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation9
LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-69
Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome9
Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats9
Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells9
Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer9
Lnc-GULP1–2:1 affects granulosa cell proliferation by regulating COL3A1 expression and localization9
WISP2 promotes cell proliferation via targeting ERK and YAP in ovarian cancer cells9
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia9
ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis9
LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis9
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present9
The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve8
Plumbagin rescues the granulosa cell’s pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome8
Fertility care amidst the COVID19 pandemic: the American experience8
The challenge of ovarian tissue culture: 2D versus 3D culture8
Amniotic fluid-derived exosomes attenuated fibrotic changes in POI rats through modulation of the TGF-β/Smads signaling pathway8
Effects and mechanisms of mUCMSCs on ovarian structure and function in naturally ageing C57 mice8
Troxerutin protects against DHT-induced polycystic ovary syndrome in rats8
LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis8
Ovarian sex cord stromal tumours: analysis of the clinical and sonographic characteristics of different histopathologic subtypes8
Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors8
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer8
Ovarian reserve in nigerian women with sickle cell anaemia: a cross- sectional study8
Laser-assisted hatching in lower grade cleavage stage embryos improves blastocyst formation: results from a retrospective study8
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance8
The presence of living endometrial cells in ovarian endometriotic cyst fluid may contribute to the recurrence of endometriosis after surgical excision of endometriomas8
Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China8
microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway8
Short (seven days) versus standard (fourteen days) oestrogen administration in a programmed frozen embryo transfer cycle: a retrospective cohort study8
Ovarian inguinal hernia – a possibility in MURCS syndrome8
miR-4324 inhibits ovarian cancer progression by targeting FEN18
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer8
CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K38
Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors8
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy8
Assisted hatching of vitrified-warmed blastocysts prior to embryo transfer does not improve pregnancy outcomes8
Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey8
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer8
Small RNA sequencing reveals distinct nuclear microRNAs in pig granulosa cells during ovarian follicle growth8
Ovarian metastasis from nongynecologic primary sites: a retrospective analysis of 177 cases and 13-year experience8
Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis8
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA68
High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer8
Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics8
Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors8